| Authors: |
Chang AY; Oncology Research & Development, Pfizer Inc, Pearl River, New York, USA., Zhou YJ; Oncology Research & Development, Pfizer Inc, Pearl River, New York, USA., Iyengar S; Emerging Science & Innovation, Pfizer Inc, Pearl River, New York, USA., Pobiarzyn PW; Oncology Research & Development, Pfizer Inc, Pearl River, New York, USA., Tishchenko P; Oncology Research & Development, Pfizer Inc, Pearl River, New York, USA., Shah KM; Oncology Research & Development, Pfizer Inc, Pearl River, New York, USA., Wheeler H; Medicine Design, Worldwide Research & Development, Pfizer Inc, Groton, Connecticut, USA., Wang YM; Medicine Design, Worldwide Research & Development, Pfizer Inc, Groton, Connecticut, USA., Loria PM; Medicine Design, Worldwide Research & Development, Pfizer Inc, Groton, Connecticut, USA., Loganzo F; Oncology Research & Development, Pfizer Inc, Pearl River, New York, USA., Woo SR; Oncology Research & Development, Pfizer Inc, Pearl River, New York, USA. Electronic address: realwoomir@gmail.com. |